SJM
21
2
AVY
50
2
HRL
41
2
GOOGL
45
-9
FLR
55
6
MCO
75
2
CNP
63
3
CTSH
54
-2
EXR
60
3
INTU
54
3
D
45
5
EMC
53
5
MRK
27
5
KIM
76
2
AIV
70
2
PEG
67
5
CAT
62
7
DGX
50
2
FMC
33
2
OI
42
5
SJM
21
2
AVY
50
2
HRL
41
2
GOOGL
45
-9
FLR
55
6
MCO
75
2
CNP
63
3
CTSH
54
-2
EXR
60
3
INTU
54
3
D
45
5
EMC
53
5
MRK
27
5
KIM
76
2
AIV
70
2
PEG
67
5
CAT
62
7
DGX
50
2
FMC
33
2
OI
42
5
Financhill
Back

Beam Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Buy
52

BEAM
Beam Therapeutics

Last Price:
25.04
Seasonality Move:
42.3%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Buy
52
Beam Therapeutics (BEAM) is a Buy

Is Beam Therapeutics a Buy, Sell or Hold?

  • The current Beam Therapeutics [BEAM] share price is $23.58. The Score for BEAM is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • BEAM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.00. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BEAM Stock Price Chart

What is Beam Therapeutics's stock price today?

  • The Beam Therapeutics share price today is $23.58
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BEAM is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

BEAM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 45.28 Sell
Chaikin Money Flow: -643841 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.11 - 26.57) Sell
Bollinger Bands (100): (22.91 - 27.69) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.83 Sell
Relative Strength Index (14 RSI): 9.64 Sell
Chaikin Money Flow: -11653674 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.08 - 12.98) Sell
Bollinger Bands (100): (10.5 - 14.68) Sell

BEAM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.41 Sell
20-day SMA: 24.76 Sell
50-day SMA: 24.54 Sell
200-day SMA: 26.78 Sell
8-day EMA: 24.94 Sell
20-day EMA: 24.97 Sell
50-day EMA: 24.79 Sell
200-day EMA: 26.05 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.54 Sell
20-day SMA: 10.1 Sell
50-day SMA: 11.82 Sell
200-day SMA: 12.75 Sell
8-day EMA: 7.04 Sell
20-day EMA: 9.29 Sell
50-day EMA: 11.19 Sell
200-day EMA: 11.43 Sell

Beam Therapeutics Earnings Growth & BEAM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.58 per share, and a decrease next year of $0.04 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Beam Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):